Canopy Growth Corp Share Price Toronto S.E.
Equities
CGC
CA1380351009
Pharmaceuticals
End-of-day quote
Other stock markets
|
||
- CAD | - |
31/05 | Piper Sandler Reviews Canopy Growth's Q4 | MT |
30/05 | Transcript : Canopy Growth Corporation, Q4 2024 Earnings Call, May 30, 2024 |
Sales 2024 | 344M 252M 20.96B | Sales 2025 * | 302M 221M 18.39B | Capitalization | 870M 638M 53.01B |
---|---|---|---|---|---|
Net income 2024 | -657M -482M -40.04B | Net income 2025 * | -126M -92.43M -7.68B | EV / Sales 2024 | 4.23 x |
Net Debt 2024 | 394M 289M 24B | Net Debt 2025 * | 434M 319M 26.47B | EV / Sales 2025 * | 4.32 x |
P/E ratio 2024 |
-1.33
x | P/E ratio 2025 * |
-8.74
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 99.73% |
Latest transcript on Canopy Growth Corp
Managers | Title | Age | Since |
---|---|---|---|
David Klein
CEO | Chief Executive Officer | 60 | 01/18/01 |
Judy Hong
DFI | Director of Finance/CFO | 52 | 02/19/02 |
Tyler Burns
IRC | Investor Relations Contact | - | 01/16/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
David Klein
CEO | Chief Executive Officer | 60 | 01/18/01 |
David Lazzarato
CHM | Chairman | 69 | 31/20/31 |
Theresa Yanofsky
BRD | Director/Board Member | 67 | 31/20/31 |
1st Jan change | Capi. | |
---|---|---|
+37.12% | 6.02B | |
-22.80% | 4.19B | |
+5.44% | 3.25B | |
-19.45% | 2.87B | |
-10.35% | 2.37B | |
+42.72% | 1.89B | |
-5.87% | 1.58B | |
-18.53% | 1.54B | |
-15.33% | 1.5B |
- Stock Market
- Equities
- WEED Stock
- CGC Stock